In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22625-57-6, name is 5-(Chloromethyl)oxazolidin-2-one, introducing its new discovery. Quality Control of 5-(Chloromethyl)oxazolidin-2-one
Aluminium-Catalysed Oxazolidinone Synthesis and their Conversion into Functional Non-Symmetrical Ureas
An efficient and practical aluminium-catalysed approach towards a range of functional oxazolidinones is reported. The method is based on cheap and readily available starting materials including terminal and internal (bicyclic) epoxides and phenyl carbamate. The oxazolidinones serve as highly useful synthons for the high yield preparation of non-symmetrical ureas by nucleophilic ring-opening affording the targeted urea compounds with excellent functional group diversity, high regioselectivity and isolated yields up to >99%.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22625-57-6, and how the biochemistry of the body works.Quality Control of 5-(Chloromethyl)oxazolidin-2-one
Reference：
Oxazolidine – Wikipedia,
Oxazolidine | C3H1444NO – PubChem